Minimally Invasive Stage 1 to Protect Against the Risk of Liver Failure: Results from the Hepatocellular Carcinoma Series of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy Italian Registry
Matteo Serenari(Azienda USL di Bologna), Elio Jovine(Azienda USL di Bologna), Umberto Cillo(University of Padua), Marco Vivarelli(Marche Polytechnic University), Matteo Cescon(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Marco Massani(AULSS 2 Marca Trevigiana), Francesca Ratti(Vita-Salute San Raffaele University), Matteo Zanello(Ospedale Maggiore), Federico Mocchegiani(Marche Polytechnic University), Nicola Guglielmo(Ospedale di Latisana), M. Colledan(University Hospital Frankfurt), Vincenzo Mazzaferro(Fondazione IRCCS Istituto Nazionale dei Tumori), Raffaele Dalla Valle(University of Parma), Bruno Nardo, Marco Colasanti(IRCCS San Camillo Hospital), Luca Aldrighetti(Vita-Salute San Raffaele University), Giuseppe Maria Ettorre(IRCCS San Camillo Hospital), Fabrizio Di Benedetto(University of Modena and Reggio Emilia)
Cited by 24
Related Papers
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
|New England Journal of Medicine|1996|7.1k
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
|The Lancet Oncology|2008|2k
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
|New England Journal of Medicine|2008|1.3k
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
|The Lancet Oncology|2015|1.1k
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821